Advanced search
Publication Cover
Gynecological Endocrinology Volume 38, 2022 - Issue 2
Submit an article Journal homepage
1,008
Views
2
CrossRef citations to date
0
Altmetric
POLYCYSTIC OVARY SYNDROME

Myoinositol versus metformin pretreatment in GnRH-antagonist cycle for women with PCOS undergoing IVF: a double-blinded randomized controlled study

Keerthana Rajasekarana Department of Obstetrics & Gynaecology, All India Institute of Medical Sciences (AIIMS), New Delhi, IndiaView further author information
,
Neena Malhotraa Department of Obstetrics & Gynaecology, All India Institute of Medical Sciences (AIIMS), New Delhi, IndiaCorrespondence[email protected]
View further author information
,
Reeta Maheya Department of Obstetrics & Gynaecology, All India Institute of Medical Sciences (AIIMS), New Delhi, IndiaView further author information
,
Rajesh Khadgawatb Department of Endocrinology, All India Institute of Medical Sciences (AIIMS), New Delhi, IndiaView further author information
&
Mani Kalaivanic Department of Biostatistics, All India Institute of Medical Sciences, New Delhi, IndiaView further author information
Pages 140-147 | Received 29 Mar 2021, Accepted 13 Sep 2021, Published online: 30 Sep 2021

References

  • Joshi B, Mukherjee S, Patil A, et al. A cross-sectional study of polycystic ovarian syndrome among adolescent and young girls in Mumbai, India. Indian J Endocrinol Metab. 2014;18(3):317–324.
  • Angik R. A comparative study of metabolic and hormonal effects of myoinositol VS metformin in women with polycystic ovary syndrome: a randomised controlled trial. Int J Reprod Contracept Obstet Gynecol. 2015;4:1.
  • Rotterdam ESHRE/ASRM-sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod. 2004;19(1):41–47.
  • Kahsar-Miller MD, Nixon C, Boots LR, et al. Prevalence of polycystic ovary syndrome (PCOS) in first-degree relatives of patients with PCOS. Fertil Steril. 2001;75(1):53–58.
  • Geller DH, Pacaud D, Gordon CM, et al. State of the art review: emerging therapies: the use of insulin sensitizers in the treatment of adolescents with polycystic ovary syndrome (PCOS). Int J Pediatr Endocrinol. 2011;2011(1):9.
  • Tang T, Glanville J, Orsi N, et al. The use of metformin for women with PCOS undergoing IVF treatment. Hum Reprod. 2006;21(6):1416–1425.
  • Tso LO, Costello MF, Albuquerque LET, et al. Metformin treatment before and during IVF or ICSI in women with polycystic ovary syndrome. Cochrane Database Syst Rev. 2014;(11):CD006105. PMID 19370625
  • Papaleo E, Unfer V, Baillargeon JP, et al. Myo-inositol may improve oocyte quality in intracytoplasmic sperm injection cycles. A prospective, controlled, randomized trial. Fertil Steril. 2009;91(5):1750–1754.
  • Mendoza N, Diaz-Ropero MP, Aragon M, et al. Comparison of the effect of two combinations of myo-inositol and D-chiro-inositol in women with polycystic ovary syndrome undergoing ICSI: a randomized controlled trial. Gynecol Endocrinol. 2019;35(8):695–700.
  • Lesoine B, Regidor PA. Prospective randomized study on the influence of myoinositol in PCOS women undergoing IVF in the improvement of oocyte quality, fertilization rate, and embryo quality. Int J Endocrinol. 2016;2016:4378507–4378505.
  • Piomboni P, Focarelli R, Capaldo A, et al. Protein modification as oxidative stress marker in follicular fluid from women with polycystic ovary syndrome: the effect of inositol and metformin. J Assist Reprod Genet. 2014;31(10):1269–1276.
  • Showell MG, Mackenzie‐Proctor R, Jordan V, et al. Inositol for subfertile women with polycystic ovary syndrome. Cochrane Database Syst Rev. 2018;12(12):CD012378.
  • Medicine AS, In R, Alpha Scientists In Reproductive Medicine. The Alpha consensus meeting on cryopreservation key performance indicators and benchmarks: proceedings of an expert meeting. Reprod Biomed Online. 2012;25(2):146–167.
  • The Istanbul consensus workshop on embryo assessment: proceedings of an expert meeting. Hum Reprod. 2011;26(6):1270–1283.
  • Ovarian Hyperstimulation Syndrome, Management (Green-top Guideline No. 5) [Internet]. Royal College of obstetricians & gynaecologists.
  • Smith V, Osianlis T, Vollenhoven B. Prevention of ovarian hyperstimulation syndrome: a review. Obstet Gynecol Int. 2020;2015:12–11.
  • Mourad S, Brown J, Farquhar C. Interventions for the prevention of OHSS in ART cycles: an overview of Cochrane reviews. Cochrane Database Syst Rev. 2017;1:CD012103–20.
  • Diamanti-Kandarakis E, Christakou CD, Kandaraki E, et al. Metformin: an old medication of new fashion: evolving new molecular mechanisms and clinical implications in polycystic ovary syndrome. Eur J Endocrinol. 2010;162(2):193–212.
  • Doldi N, Persico P, Sebastiano FD, et al. Gonadotropin-releasing hormone antagonist and metformin for treatment of polycystic ovary syndrome patients undergoing in vitro fertilization–embryo transfer. Gynecol Endocrinol. 2006;22(5):235–238.
  • Jacob SL, Field HP, Calder N, et al. Anti-Müllerian hormone reflects the severity of polycystic ovary syndrome. Clin Endocrinol. 2017;86(3):395–400.
  • Morley LC, Tang T, Yasmin E, et al. Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility. Cochrane Database Syst Rev. 2017;11:CD003053.
  • Lashen H. Role of metformin in the management of polycystic ovary syndrome. Ther Adv Endocrinol Metab. 2010;1(3):117–128.
  • Bhide P, Pundir J, Gudi A, et al. The effect of myo-inositol/di-chiro-inositol on markers of ovarian reserve in women with PCOS undergoing IVF/ICSI: a systematic review and Meta-analysis. Acta Obstet Gynecol Scand. 2019;98(10):1235–1244.
  • Homburg R, Crawford G. The role of AMH in anovulation associated with PCOS: a hypothesis. Hum Reprod. 2014;29(6):1117–1121.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.